Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARα) by clofibrate in jerboa tissues

Microscopy Research and Technique

Volumn 61, Issue 2, 2003, Pages 185-190

  Anisaguine Safir, Siham ^a   Bianchi, Arnaud ^b   Collet, Philippe ^b   Huin Schohn, Cécile ^b   Jeanvoine, Adeline ^b   Bécuwe, Philippe ^b   Krémarik Bouillaud, Pascaline ^b   Domenjoud, Lionel ^b   Keller, Jean Marie ^b   Schohn, Hervé ^b   Dauça, Michel ^b  

^a FACULTÉ DES SCIENCES BEN M SIK   (Morocco)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Clofibrate; Jerboa; Peroxisome proliferator; Peroxisome proliferator activated receptor

Indexed keywords

BIOCHEMISTRY; CYTOLOGY; TISSUE; TRANSCRIPTION;

CLOFIBRATE; EXPRESSION PATTERNS; JERBOA; LIPID HOMEOSTASIS; LIPID METABOLISMS; NUCLEAR HORMONE RECEPTOR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PEROXISOME PROLIFERATORS; POLYCLONAL; WESTERN-BLOTTING;

FATTY ACIDS;

CELL NUCLEUS RECEPTOR; CLOFIBRATE; FATTY ACID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYCLONAL ANTIBODY; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; COLON; CONFERENCE PAPER; CONTROLLED STUDY; DUODENUM; GENE CONTROL; GENE EXPRESSION; HUMAN; JERBOA; KIDNEY; LIPID METABOLISM; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; TARGET CELL; TISSUE SPECIFICITY; WESTERN BLOTTING;

JACULUS; JACULUS ORIENTALIS;

EID: 0038558123     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10328     Document Type: Conference Paper

References (41)

1. Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254.
2. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPA-R-α, -β and -γ in the adult rat. Endocrinology 137:354-366.
3. Brandt JM, Djouadi F, Kelly DP. 1998. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 273:23786-23792.
4. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P. 2001. A PPARgamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7:161-171.
5. Chawla A, Lazar MA. 1994. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival, Proc Natl Acad Sci USA 91:1786-1790.
6. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. 1994. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800.
7. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B. 2001. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:23-24.
8. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
9. Cohen AJ, Grasso P. 1981. Review of the hepatic response to hypolipidemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet Toxicol 19:585-605.
10. Corton JC, Lapinskas PJ, Gonzalez FJ. 2000. Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutation Res 448:139-151.
11. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, Kelly OP. 1998. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. J Clin Invest 102:1083-1091.
12. El Hilali M, Weillat JP. 1975. Jaculus orientalis: a true hibernator. Mammalia 39:401-404.
13. El Kebbaj MS, Cherkaoui-Malki M, Latruffe N. 1996. Properties of peroxisomes from jerboa (Jaculus orientalis). Eur J Cell Biol 70: 150-156.
14. Escher P, Wahli W. 2000. Peroxisome proliferator-activated receptors insight into multiple cellular functions. Mutat Res 448:121-138.
15. Fajas L, Fruchart JC, Auwerx J. 1998. PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett 438:55-60.
16. Gebel T, Arand M, Oesch F. 1992. Induction of the peroxisome proliferator-activated receptor by fenofibrate. FEBS Lett 309:37-40.
17. Goettlicher M, Widmark E, Li Q, Gustafsson JA 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89:4653-4657.
18. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP. 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91:11012-11016.
19. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ,Yeldandi AV, Rao MS, Reddy JK. 1999. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 274:19228-19236.
20. Huber W, Grasl-Kraup B, Schulte-Hermann R. 1996. Hepatocarcinogenic potential of di-(2-ethylhexyl) phthalate in rodents and its implications for human risk assessment. Crit Rev Toxicol 26:365-481.
21. Huin C, Corriveau L, Bianchi A, Keller JM, Collet P, Krémarik-Bouillaud P, Domenjoud L, Bécuwe P, Schohn H, Ménard D, Dauça M. 2000. Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. J Histochem Cytochem 48:603-611.
22. Issemann I, Green S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650.
23. Kabine M, Cherkaoui-Malki M, Clémencet MC, El Kebbaj MS, Latruffe N. 1998. Peroxisomal changes during hibernation of jerboa (Jaculus orientalis). JAOCS 75:275-280.
24. Keller JM, Collet P, Bianchi A, Huin C, Bouillaud-Kremarik P, Becuwe P, Schohn H, Domenjoud L, Dauça M. 2000. Implications of peroxisome proliferator-activated receptors (PPARs) in development, cell life status and diseases. Int J Dev Biol 44:429-442.
25. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptative response to fasting. J Clin Invest 103:1489-1498.
26. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358:771-774.
27. Kole G, Roessner A, Themann H. 1976. Effect of clofibrate (α-p-chlorophenoxy-isobutyryl-ethyl-ester) on male rat liver. Virchow Arch Abst B 22:73-87.
28. Lalwani ND, Reddy MK, Qureshi SA, Reddy JK. 1981. Development of hepatocellular carcinoma and increased peroxisomal fatty acid β-oxidation in rat fed [4-chloro-6-(2,3-xylidino)-2-pyrinidinylthiol] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis 7:645-650.
29. Latruffe N. 1992. Les peroxysomes et la prolifération cellulaire, ou la prise en considération d'un organite méconnu. Med Sci 8:239-248.
30. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J. 1997. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPAR-gamma activators. J Biol Chem 272:28210-28217.
31. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D. 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273:8560-8573.
32. Oliver WR, Shenk JL, Snaith MR, Russel CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM. 2001. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98: 5306-5311.
33. Qi C, Zhu Y, Pan J, Usuda N, Maeda N, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK. 1999. Absence of spontaneous peroxisome proliferation in enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism. J Biol Chem 274:15775-15780.
34. Reddy JK, Krishnakantha TP. 1975. Hepatic peroxisome proliferation:induction by two novel compounds structurally unrelated to clofibrate. Science 190:787-789.
35. Schoonjans K, Staels B, Auwerx J. 1996. The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochem Biophys Acta 1302:93-109.
36. Steineger H, Sorensen HN, Tugwood JD, Skrede S, Spydevold O, Gautvik KM. 1994. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty acid-induced transcription. Eur J Biochem 225:967-974.
37. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11:433-439.
38. Van den Bosch H, Schutgens RB, Wanders RJ, Tager JM. 1992. Biochemistry of peroxisomes. Ann Rev Biochem 61:157-197.
39. Willson TM, Brown PJ, Sternbach DD, Henke BR. 2000. The PPARs: from orphan receptors to drug discovery. J Med Chem 43:527-550.
40. Winer BJ. 1971. In: Statistical principles in experimental design, 2nd ed., Vol 1. New York: McGraw-Hill.
41. Yu GS, Lu YC, Gulick T. 1998. Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase I beta gene promoters by fatty acid enzyme substrate. J Biol Chem 273:32901-32909.